These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 28208119)
1. HIV Prevention: Opportunities and Challenges. Marrazzo JM Top Antivir Med; 2017; 24(4):123-126. PubMed ID: 28208119 [TBL] [Abstract][Full Text] [Related]
2. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial. Antoni G; Tremblay C; Delaugerre C; Charreau I; Cua E; Rojas Castro D; Raffi F; Chas J; Huleux T; Spire B; Capitant C; Cotte L; Meyer L; Molina JM; Lancet HIV; 2020 Feb; 7(2):e113-e120. PubMed ID: 31784343 [TBL] [Abstract][Full Text] [Related]
3. Should we fear resistance from tenofovir/emtricitabine preexposure prophylaxis? Parikh UM; Mellors JW Curr Opin HIV AIDS; 2016 Jan; 11(1):49-55. PubMed ID: 26633640 [TBL] [Abstract][Full Text] [Related]
4. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. Molina JM; Charreau I; Spire B; Cotte L; Chas J; Capitant C; Tremblay C; Rojas-Castro D; Cua E; Pasquet A; Bernaud C; Pintado C; Delaugerre C; Sagaon-Teyssier L; Mestre SL; Chidiac C; Pialoux G; Ponscarme D; Fonsart J; Thompson D; Wainberg MA; Doré V; Meyer L; Lancet HIV; 2017 Sep; 4(9):e402-e410. PubMed ID: 28747274 [TBL] [Abstract][Full Text] [Related]
5. Nondaily preexposure prophylaxis for HIV prevention. Anderson PL; García-Lerma JG; Heneine W Curr Opin HIV AIDS; 2016 Jan; 11(1):94-101. PubMed ID: 26633641 [TBL] [Abstract][Full Text] [Related]
6. Maximizing the Benefits of HIV Preexposure Prophylaxis. Buchbinder SP Top Antivir Med; 2018 Apr; 25(4):138-142. PubMed ID: 29689539 [TBL] [Abstract][Full Text] [Related]
7. An intravaginal ring for the sustained delivery of tenofovir disoproxil fumarate. Baum MM; Butkyavichene I; Churchman SA; Lopez G; Miller CS; Smith TJ; Moss JA Int J Pharm; 2015 Nov; 495(1):579-587. PubMed ID: 26386138 [TBL] [Abstract][Full Text] [Related]
8. Pre-exposure prophylaxis to prevent HIV infection: current status, future opportunities and challenges. Krakower DS; Mayer KH Drugs; 2015 Feb; 75(3):243-51. PubMed ID: 25673022 [TBL] [Abstract][Full Text] [Related]
9. Safety of oral tenofovir disoproxil fumarate-based pre-exposure prophylaxis for HIV prevention. Mugwanya KK; Baeten JM Expert Opin Drug Saf; 2016; 15(2):265-73. PubMed ID: 26634852 [TBL] [Abstract][Full Text] [Related]
10. Correlates of Adherence to Oral and Vaginal Pre-exposure Prophylaxis (PrEP) Among Adolescent Girls and Young Women (AGYW) Participating in the MTN-034/REACH Trial. Ngure K; Browne EN; Reddy K; Friedland BA; van der Straten A; Palanee-Phillips T; Nakalega R; Gati B; Kalule HN; Siziba B; Soto-Torres L; Nair G; Garcia M; Celum C; Roberts ST AIDS Behav; 2024 Sep; 28(9):2990-3000. PubMed ID: 38852114 [TBL] [Abstract][Full Text] [Related]
11. Safety of oral tenofovir disoproxil fumarate-based HIV pre-exposure prophylaxis use in lactating HIV-uninfected women. Mugwanya KK; John-Stewart G; Baeten J Expert Opin Drug Saf; 2017 Jul; 16(7):867-871. PubMed ID: 28571500 [TBL] [Abstract][Full Text] [Related]
12. Daily or on-demand oral tenofovir disoproxil fumarate/emtricitabine for HIV pre-exposure prophylaxis: experience from a hospital-based clinic in France. Noret M; Balavoine S; Pintado C; Siguier M; Brun A; Bauer R; Loze B; Leplatois A; Aslan A; Moudachirou K; Delaugerre C; Rozenbaum W; Molina JM AIDS; 2018 Sep; 32(15):2161-2169. PubMed ID: 30212403 [TBL] [Abstract][Full Text] [Related]
13. InterPrEP: internet-based pre-exposure prophylaxis with generic tenofovir disoproxil fumarate/emtrictabine in London - analysis of pharmacokinetics, safety and outcomes. Wang X; Nwokolo N; Korologou-Linden R; Hill A; Whitlock G; Day-Weber I; McClure MO; Boffito M HIV Med; 2018 Jan; 19(1):1-6. PubMed ID: 28657199 [TBL] [Abstract][Full Text] [Related]
14. Preexposure prophylaxis-selected drug resistance decays rapidly after drug cessation. Weis JF; Baeten JM; McCoy CO; Warth C; Donnell D; Thomas KK; Hendrix CW; Marzinke MA; Mugo N; Matsen FA; Celum C; Lehman DA; AIDS; 2016 Jan; 30(1):31-5. PubMed ID: 26731753 [TBL] [Abstract][Full Text] [Related]
15. Pre-Exposure Prophylaxis for HIV Prevention in Women: Current Status and Future Directions. Hodges-Mameletzis I; Fonner VA; Dalal S; Mugo N; Msimanga-Radebe B; Baggaley R Drugs; 2019 Aug; 79(12):1263-1276. PubMed ID: 31309457 [TBL] [Abstract][Full Text] [Related]
16. Medication Adherence in a Nationwide Cohort of Veterans Initiating Pre-exposure Prophylaxis (PrEP) to Prevent HIV Infection. van Epps P; Maier M; Lund B; Howren MB; Beck B; Beste L; Skolnik A; Vaughan-Sarrazin M; Ohl ME J Acquir Immune Defic Syndr; 2018 Mar; 77(3):272-278. PubMed ID: 29210835 [TBL] [Abstract][Full Text] [Related]
17. Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns. Tetteh RA; Yankey BA; Nartey ET; Lartey M; Leufkens HG; Dodoo AN Drug Saf; 2017 Apr; 40(4):273-283. PubMed ID: 28130774 [TBL] [Abstract][Full Text] [Related]
18. Estimating efficacy in a randomized trial with product nonadherence: application of multiple methods to a trial of preexposure prophylaxis for HIV prevention. Murnane PM; Brown ER; Donnell D; Coley RY; Mugo N; Mujugira A; Celum C; Baeten JM; Am J Epidemiol; 2015 Nov; 182(10):848-56. PubMed ID: 26487343 [TBL] [Abstract][Full Text] [Related]
19. Preexposure Prophylaxis with Tenofovir/Emtricitabine Prevents HIV Infection In Men who Have Unprotected Anal Intercourse. Ebell MH Am Fam Physician; 2016 Mar; 93(6):520. PubMed ID: 26977839 [No Abstract] [Full Text] [Related]
20. HIV preexposure prophylaxis with tenofovir disoproxil fumarate/emtricitabine and changes in kidney function and tubular health. Ascher SB; Scherzer R; Estrella MM; Shigenaga J; Spaulding KA; Glidden DV; Mehrotra ML; Defechereux P; Gandhi M; Grant RM; Shlipak MG; Jotwani V AIDS; 2020 Apr; 34(5):699-706. PubMed ID: 31794523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]